{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T15:52:56Z","timestamp":1694965976026},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1988,4,1]],"date-time":"1988-04-01T00:00:00Z","timestamp":575856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1988,4]]},"DOI":"10.1007\/bf01963075","type":"journal-article","created":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T22:00:04Z","timestamp":1122933604000},"page":"178-182","source":"Crossref","is-referenced-by-count":2,"title":["Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients"],"prefix":"10.1007","volume":"7","author":[{"given":"C.","family":"Verhagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"Pauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Bois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01963075_CR1","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1093\/infdis\/135.Supplement_2.S421","volume":"134","author":"G.P. Bodey","year":"1976","unstructured":"Bodey, G.P., Rodriguez, V., Valdivieso, M., Feld, R. Amikacin for treatment of infections in patients with malignant diseases. Journal of Infectious Diseases 1976, 134: S421-S427.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01963075_CR2","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1001\/archinte.1984.00350210078014","volume":"144","author":"V. Fainstein","year":"1984","unstructured":"Fainstein, V., Bodey, G.P., Bolivar, R., Elting, L., McCredie, K.B., Keating, M.J. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. Archives of Internal Medicine 1984, 144: 1766\u20131770.","journal-title":"Archives of Internal Medicine"},{"key":"BF01963075_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00005792-197903000-00004","volume":"58","author":"M.J. Keating","year":"1979","unstructured":"Keating, M.J., Bodey, G.P., Valdivieso, M., Rodriguez, V. A randomized comparative trial of three aminoglycosides: comparison of continous infusions of gentamicin, amikacin and sisomycin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine 1979, 58: 159\u2013170.","journal-title":"Medicine"},{"key":"BF01963075_CR4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archinte.1982.00340220079015","volume":"142","author":"D.J. Winston","year":"1982","unstructured":"Winston, D.J., Ho, W.G., Young, L.S., Hewit, W.L., Gale, R.P. Piperacillin plus amikacin therapy versus carbenicillin plus amikacin therapy in febrile granulocytopenic patients. Archives of Internal Medicine 1982, 142: 1663\u20131667.","journal-title":"Archives of Internal Medicine"},{"key":"BF01963075_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jac\/16.2.183","volume":"16","author":"S.M. Norris","year":"1985","unstructured":"Norris, S.M., Guenthner, S.H., Wenzel, R.P. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures. Journal of Antimicrobial Chemotherapy 1985, 16: 183\u2013188.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01963075_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/17.1.5","volume":"17","author":"N. Rolinson","year":"1986","unstructured":"Rolinson, N. Beta-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1986, 17: 5\u201336.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01963075_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0163-4453(85)93063-4","volume":"11","author":"J.P. Donnelly","year":"1985","unstructured":"Donnelly, J.P., Marcus, R.E., Goldman, J.M., Cohen, J., Worsley, A.M., Catovsky, D., Darrell, J.H., Want, S.V., Galton, D.A.G. Ceftazidime as first line therapy for fever in acute leukaemia. Journal of Infection 1985, 11: 205\u2013215.","journal-title":"Journal of Infection"},{"issue":"Supplement A","key":"BF01963075_CR8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/12.suppl_A.101","volume":"12","author":"V. Fainstein","year":"1983","unstructured":"Fainstein, V., Bodey, G.P., Elting, L., Bolivar, R., Keating, M.J., McCredle, K.B., Valdivieso, M. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 101\u2013110.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement 2A","key":"BF01963075_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(85)90265-7","volume":"79","author":"P.A. Pizzo","year":"1985","unstructured":"Pizzo, P.A., Thaler, M., Hathorn, J., Skelton, J., McKnight, J., Rubin, M., Browne, M., Longo, D., Cotton, D., Gress, J., Marshall, D. New beta-lactam antibiotics in granulocytopenic patients, new options and new questions. American Journal of Medicine 1985, 79, Supplement 2A: 75\u201382.","journal-title":"American Journal of Medicine"},{"key":"BF01963075_CR10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","volume":"315","author":"P.A. Pizzo","year":"1986","unstructured":"Pizzo, P.A., Hathorn, J.W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., Rubin, M., Skelton, J., Thaler, M., Wesley, R. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 1986, 315: 552\u2013558.","journal-title":"New England Journal of Medicine"},{"issue":"Supplement A","key":"BF01963075_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/12.suppl_A.93","volume":"12","author":"B.E. Pauw De","year":"1983","unstructured":"De Pauw, B.E., Kauw, F., Muytjens, H., Williams, K.J., Bothof, T. Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 93\u201399.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01963075_CR12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.28.6.824","volume":"28","author":"B.E. Pauw De","year":"1985","unstructured":"De Pauw, B.E., Williams, K., De Neef, J., Bothof, T., De Witte, T., Holdrinet, R., Haanen, C. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrobial Agents and Chemotherapy 1985, 28: 824\u2013828.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01963075_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.31.2.191","volume":"31","author":"C. Verhagen","year":"1987","unstructured":"Verhagen, C., De Pauw, B.E., De Witte, T., Janssen, J., Williams, K., De Mulder, P., Bothof, T. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrobial Agents and Chemotherapy 1987, 31: 191\u2013196.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement 2A","key":"BF01963075_CR14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0002-9343(85)90268-2","volume":"79","author":"B. R. Meyers","year":"1985","unstructured":"Meyers, B. R. Comparative toxicities of the third-generation cephalosporins. American Journal of Medicine 1985, 79, Supplement 2A: 96\u2013103.","journal-title":"American Journal of Medicine"},{"key":"BF01963075_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00320893","volume":"52","author":"C. Verhagen","year":"1986","unstructured":"Verhagen, C., De Pauw, B.E., De Witte, T., Holdrinet, R.S.G., Janssen, J.Th.P., Williams, K.J. Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplantation patients. Blut 1986, 52: 333\u2013339.","journal-title":"Blut"},{"key":"BF01963075_CR16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-97-4-503","volume":"97","author":"J.C. Wade","year":"1982","unstructured":"Wade, J.C., Schimpff, S.C., Newman, K.A., Wiernik, P.H. Staphylococcus epidermidis: An increasing cause of infection in patients with granulocytopenia. Annals of Internal Medicine 1982, 97: 503\u2013508.","journal-title":"Annals of Internal Medicine"},{"key":"BF01963075_CR17","first-page":"193","volume":"19","author":"G.P. Bodey","year":"1982","unstructured":"Bodey, G.P., Bolivar, R., Fainstein, V. Infectious complications in leukemic patients. Seminars in Hematology 1982, 19: 193\u2013226.","journal-title":"Seminars in Hematology"},{"key":"BF01963075_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.29.2.263","volume":"29","author":"J. Klastersky","year":"1986","unstructured":"Klastersky, J., Glauser, M.P., Schimpff, S.C., Zinner, S.H., Gaya, H., EORTC Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infections in febrile granulocytopenic patients. Antimicrobial Agents and Chemotherapy 1986, 29: 263\u2013270.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01963075_CR19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"G.P. Bodey","year":"1966","unstructured":"Bodey, G.P., Buckley, M., Sathi, Y.S. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine 1966, 64: 328\u2013339.","journal-title":"Annals of Internal Medicine"},{"issue":"Supplement 2A","key":"BF01963075_CR20","first-page":"2","volume":"79","author":"H.C. Neu","year":"1985","unstructured":"Neu, H.C. Relation of structural properties of betalactam antibiotics to antibacterial activity. American Journal of Medicine 1985, 79, Supplement 2A: 2\u201313.","journal-title":"American Journal of Medicine"},{"key":"BF01963075_CR21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archinte.1975.00330050089015","volume":"135","author":"E.A. Sickles","year":"1975","unstructured":"Sickles, E.A., Greene, W.H., Wiernik, P.H. Clinical presentation of infection in granulocytopenic patients. Archives of Internal Medicine 1975, 135: 715\u2013719.","journal-title":"Archives of Internal Medicine"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01963075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01963075\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01963075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T17:46:13Z","timestamp":1557769573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01963075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988,4]]}},"alternative-id":["BF01963075"],"URL":"https:\/\/doi.org\/10.1007\/bf01963075","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,4]]}}}